Anadys Pharmaceuticals Inc.
5871 Oberlin Drive
Suite 200
San Diego,
CA 92121
United States - Map
Phone: 858-530-3600
Fax: 858-527-1540
Web Site: http://www.anadyspharma.com
| Anadys Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing medicines in the areas of hepatitis C and oncology. It develops ANA598, a small-molecule non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C; and ANA773, an oral toll-like receptor 7 agonist prodrug for the treatment of hepatitis C and cancer. The company was formerly known as Scriptgen Pharmaceuticals, Inc. and changed its name to Anadys Pharmaceuticals, Inc. in May 2000. Anadys Pharmaceuticals was founded in 1992 and is headquartered in San Diego, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Stephen T. Worland Ph.D., 51
Chief Exec. Officer, Pres, Director and Member of Strategic Committee |
$
585.00K |
$
0 | Dr. Stelios Papadopoulos Ph.D., 60
Co-Founder, Independent Director and Chairman of Corp. Governance & Nominating Committee |
$
37.00K | N/A | Ms. Elizabeth E. Reed J.D., 38
Sr. VP of Legal Affairs and Gen. Counsel |
$
301.00K |
$
0 | Dr. James L. Freddo M.D., 54
Chief Medical Officer and Sr. VP of Drug Devel. |
$
536.00K |
$
0 | Mr. Peter T. Slover , 34
Principal Financial Officer, Principal Accounting Officer and VP of Fin. and Operations |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.22% Nasdaq 
0.02 (0.77%) 
Profile
